Oral contraceptives and the risk of myocardial infarction.
about
Ischemic heart disease in women: a focus on risk factorsCombined oral contraceptives: the risk of myocardial infarction and ischemic strokeDutch women with a low birth weight have an increased risk of myocardial infarction later in life: a case control studyNovel contraceptive targets to inhibit ovulation: the prostaglandin E2 pathwayCoronary artery disease in women: a review on prevention, pathophysiology, diagnosis, and treatmentStrengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaborationIn silico identification of drug targets for antifertility from natural products by differential reaction content analysis of metabolic pathwaysThe drop that spilled the cup: acute myocardial infarction in a young woman with underlying thrombophilic polymorphisms and oral contraceptive use.Estrogens, selective estrogen receptor modulators, and a selective estrogen receptor down-regulator inhibit endothelial production of tissue factor pathway inhibitor 1.Procoagulant factors and the risk of myocardial infarction in young women.Oral contraceptives and myocardial infarction.52-year-old woman with intractable nausea and vomitingDrospirenone-containing oral contraceptive pills and the risk of venous and arterial thrombosis: a systematic review.Estrogens, progestogens and thrombosis.Combined oral contraceptives and the risk of myocardial infarction.Acute coronary syndrome in women of reproductive ageHigher risk of venous thrombosis associated with drospirenone-containing oral contraceptives: a population-based cohort study.Infertility, fertility treatment, and risk of hypertension.Combined oral contraceptives in the treatment of polycystic ovary syndrome.Contraception for the older woman: an update.Metabolic and clinical effects of progestogens.Low dose oestrogen combined oral contraception and risk of pulmonary embolism, stroke, and myocardial infarction in five million French women: cohort study.Effect of Oral Contraceptive Pills on the Blood Serum Enzymes and DNA Damage in Lymphocytes Among UsersOral contraceptive progestins and angiotensin-dependent control of the renal circulation in humansContraceptive hormone use and cardiovascular diseaseVenous thromboembolism in women.Is the difference in outcome between men and women treated by primary percutaneous coronary intervention age dependent? Gender difference in STEMI stratified on age.Risk factors for heart attack, stroke, and venous thrombosis associated with hormonal contraceptive use.Estrogen-free oral hormonal contraception: benefits of the progestin-only pill.Nicotine addiction causes unique detrimental effects on women's brains.Estrogen and thrombosis: controversies and common sense.Risk of cardiovascular events with hormonal contraception: insights from the Danish cohort study.Pharmacokinetic evaluation of desogestrel as a female contraceptive.Lipid pharmacotherapy for treatment of atherosclerosis.Hormonal contraception, thrombosis and age.Dyslipidemia and cardiovascular disease in women.Hormonal contraception: venous and arterial disease.Application of electrospun fibers for female reproductive health.Attitudes Toward Prohibiting Tobacco Sales in Pharmacy Stores Among U.S. Adults.Drospirenone-containing combined oral contraceptives and the risk of arterial thrombosis: a population-based nested case-control study.
P2860
Q22251459-CA368808-C47C-4D33-8BDA-E42050332FAFQ24187746-3631C19C-3CAF-449F-BE83-F00C4698F27CQ24803759-3C66DC5B-339E-4B97-A939-4892A28D6565Q28083349-8FCFEF8A-8B35-421B-A880-437E84B24CF4Q28219423-F50263C5-3B45-4CAE-93D6-E9912651281AQ28222847-1FFF4E10-0AFC-4C30-A8AF-0B575E6486A8Q28742763-B7A2BF32-4271-4E39-B6C1-38E5C903FECAQ30613038-198BA240-C188-4176-B310-4F324D5D202BQ33259834-D1409EF1-0149-48A7-BCD5-20F6253F0411Q33370819-3E4138AC-AFB6-429E-9291-B1C412E8E84BQ33576311-24D99DAF-171A-4ED8-8DF9-8371700112E7Q33744221-FDE53A8A-9AED-4726-A63A-2F1DF73A952DQ34636421-AD167579-42EF-4766-8FD5-FB423EBC2DF0Q35181580-B9129F02-7EE7-4BBF-B9D7-D9DC5119EF7BQ35565498-CD1EFCE8-934D-4DD1-A7EC-EC13BEA5F73AQ35577037-9166B9B7-C3FE-40D1-B393-5C3A77016985Q35664040-C507EED1-0111-4C81-8AF9-9AD9AD29D3EEQ35908838-08B35BEB-46E7-4936-B0D8-05A8390F3F63Q36080057-7F1B30BB-4BED-49F2-A57A-AAFC9D0A35BFQ36542363-78711A8A-B9D8-4860-87D1-7AD0FD20F110Q36631196-9EB06295-CC16-49F8-A817-29FEE11785BFQ36887503-25E677B7-3CCF-430C-83E0-2034A3D6B839Q37012991-1E30D5C3-144F-428B-B079-8DCC0065501EQ37016804-ACE40BC8-2477-48C0-B824-1938E800C111Q37138852-8C450FEE-2E72-45BD-8220-E79138A43401Q37238147-19A63A84-E8E5-4D5D-B991-3A007D059E0AQ37291898-2000E318-D86D-4F48-BA66-43B45BD9BF01Q37763371-FA67220D-CF4C-4F0D-BB49-2151759B7D49Q37809855-CF2F9D4F-EE6E-42A6-8C9F-571B48928200Q37864984-78BB3ADC-1241-424D-8F78-BCA926691087Q37874154-1709B310-BB2D-499D-8171-11D3A4A6EA91Q38110189-72FC249F-3494-4D70-B84E-B4149E840D8DQ38150419-A8E0E68D-6294-4315-A483-8C0C6CE4902EQ38202198-0203AE99-D441-4B80-9ACD-9AEDD2619974Q38250178-E9C2BB47-42B9-4A3F-A4A3-54D4DE3DB5D1Q38508952-FF4ECDCB-DAFF-4631-ABF0-6F752D7F3FBFQ38870757-28AE931B-51AB-43A5-9299-21A38F2582EAQ39301728-6AFB7B80-A512-469D-A7AF-E07BB259452DQ39424107-E53F1799-3406-429B-AF58-8C877A53CE26Q40553746-2751FA68-1911-4FD4-8DD1-C56DA4F88A1D
P2860
Oral contraceptives and the risk of myocardial infarction.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
2001年论文
@zh
2001年论文
@zh-cn
name
Oral contraceptives and the risk of myocardial infarction.
@en
type
label
Oral contraceptives and the risk of myocardial infarction.
@en
prefLabel
Oral contraceptives and the risk of myocardial infarction.
@en
P2093
P356
P1476
Oral contraceptives and the risk of myocardial infarction.
@en
P2093
Helmerhorst FM
Kemmeren JM
Rosendaal FR
van den Bosch MA
van der Graaf Y
P304
P356
10.1056/NEJMOA003216
P407
P577
2001-12-01T00:00:00Z